Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 May 2;22(1):163.
doi: 10.1186/s12883-022-02689-z.

The diagnostic dilemma of idiopathic intracranial hypertension in a child with acute lymphoblastic leukemia: COVID-19 or cytosine arabinoside?

Affiliations
Case Reports

The diagnostic dilemma of idiopathic intracranial hypertension in a child with acute lymphoblastic leukemia: COVID-19 or cytosine arabinoside?

Rim Rakez et al. BMC Neurol. .

Abstract

Background: Idiopathic intracranial hypertension is a rare neurological condition among children. Its manifestations vary from mild headaches to loss of vision. Although rare, COVID-19 infection and high dose cytosine arabinoside have been reported as risk factors for this neurological disorder. In patients with acute leukemia, idiopathic intracranial hypertension diagnosis is simple, but finding its etiology can be difficult.

Case presentation: We report a case of a 9-year-old boy with an ongoing treatment for T-acute lymphoblastic leukemia presenting with persistent headaches and diplopia. A diagnosis of idiopathic intracranial hypertension was retained based on clinical, imaging and laboratory findings. Due to its rarity, we describe its clinical and therapeutic features and highlight the challenging etiological dilemma between COVID-19 infection and high dose cytosine arabinoside administration.

Conclusion: Persistent headache in a pediatric patient with leukemia can be due to many neurological disorders other than leukemic relapse. Given the improvement of the neurological symptoms after the SARS-CoV-2 PCR negativization and the successful re-introduction of high dose cytosine Arabinoside, the diagnosis of idiopathic intracranial hypertension associated with Covid-19 infection was withheld.

Keywords: Acute lymphoblastic leukemia; COVID-19; Case report; Headache; Idiopathic intracranial hypertension.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Similar articles

Cited by

  • COVID-19 infection in children with blood cancer: A systematic review.
    Alhumaid S, Al Noaim K, Almuslim AA, Turkistani JA, Alqurini ZS, Alshakhs AM, Al Dossary N, Alabdulqader M, Majzoub RA, Alnaim AA, Alahmari AA, Al Ghamdi MA, Alabdulmohsen W, Alsharidah ZA, Alkhamees MS, AlAithan LA, Almurayhil AA, Almurayhil YA, Aljubran HA, Alhamdan ZS, Shabib MA, Aldandan AW, Allowaim AA, Al-Rasasi AY, Albahrani AA, Al Salem BA, Bukhamseen MS, Al Ayeyd JS, Al Mutair A, Alhumaid H, Al Alawi Z, Rabaan AA. Alhumaid S, et al. Ann Hematol. 2025 Feb;104(2):1203-1230. doi: 10.1007/s00277-024-06057-4. Epub 2024 Nov 5. Ann Hematol. 2025. PMID: 39496811 Free PMC article.

References

    1. Madriz Peralta G, Cestari DM. An update of idiopathic intracranial hypertension. Curr Opin Ophthalmol. 2018;29(6):495–502. doi: 10.1097/ICU.0000000000000518. - DOI - PubMed
    1. Smith SV, Friedman DI. The idiopathic intracranial hypertension treatment trial: a review of the outcomes. Headache. 2017;57(8):1303–1310. doi: 10.1111/head.13144. - DOI - PubMed
    1. Aylward SC, Way AL. Pediatric intracranial hypertension: a current literature review. Curr Pain Headache Rep. 2018;22(2):14. doi: 10.1007/s11916-018-0665-9. - DOI - PubMed
    1. Gaier ED, Heidary G. Pediatric idiopathic intracranial hypertension. Semin Neurol. 2019;39(6):704–710. doi: 10.1055/s-0039-1698743. - DOI - PubMed
    1. Fernández-García MÁ, Cantarín-Extremera V, Andión-Catalán M, Duat-Rodríguez A, Jiménez-Echevarría S, Bermejo-Arnedo I, et al. Secondary intracranial hypertension in pediatric patients with leukemia. Pediatr Neurol. 2017;77:48–53. doi: 10.1016/j.pediatrneurol.2017.08.013. - DOI - PubMed

Publication types

MeSH terms